SUSSX
Price
$17.40
Change
-$0.14 (-0.80%)
Updated
Sep 10 closing price
Net Assets
328.7M
VSTSX
Price
$357.72
Change
-$2.23 (-0.62%)
Updated
Sep 10 closing price
Net Assets
2.34T
Interact to see
Advertisement

SUSSX vs VSTSX

SUSSX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
SUSSX vs. VSTSX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SUSSX is a StrongBuy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.34T vs. SUSSX (329M). VSTSX pays higher dividends than SUSSX: VSTSX (1.05) vs SUSSX (0.14). SUSSX was incepted earlier than VSTSX: SUSSX (26 years) vs VSTSX (10 years). SUSSX (0.63) is less costly to investors than VSTSX (0.01). SUSSX is a more actively managed with annual turnover of: 43.00 vs. VSTSX (3.00). SUSSX has a lower initial minimum investment than VSTSX: SUSSX (10000000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 16.79 vs. SUSSX (8.37). VSTSX return over 5 years is better than : 64.06 vs. SUSSX (-7.84).
SUSSXVSTSXSUSSX / VSTSX
Total Expense Ratio0.630.016,300%
Annual Report Gross Expense Ratio0.630.016,300%
Fund Existence26 years10 years-
Gain YTD9.35212.04578%
Front LoadN/AN/A-
Min. Initial Investment1000000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets329M2.34T0%
Annual Yield % from dividends0.141.0513%
Returns for 1 year8.3716.7950%
Returns for 3 years43.4769.0763%
Returns for 5 years-7.8464.06-12%
Returns for 10 years33.54241.9414%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LYRIX33.24N/A
N/A
Lyrical US Value Equity Institutional
CAMYX33.47N/A
N/A
Cambiar International Equity Instl
RNWHX108.58N/A
N/A
American Funds New World R-5E
FZFLX5.59N/A
N/A
Fidelity® SAI Small-Mid Cap Momt Idx
UEMPX13.40N/A
N/A
UBS Emerging Markets Equity Opp P